☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Partial
Novartis Lifts Partial Clinical Trial Hold on OAV-101 Clinical Program to Treat SMA
August 3, 2021
SK Life Sciences' XCOPRI (cenobamate tablets) Receives the US FDA's Approval for Partial-Onset Seizures in Adults
November 21, 2019
Mallinckrodt Reports Results of StrataGraft Regenerative Tissue in P-III STRATA2016 Study for Deep Partial-thickness Thermal Burns
September 23, 2019
MYALEPTA® (metreleptin) receives marketing approval by EU for leptin deficiency in lipodystrophy (LD) Patients
August 2, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.